Show simple item record

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD) : a randomised controlled trial. (BICS)

dc.contributor.authorCotton, Seonaidh
dc.contributor.authorDevereux, Graham
dc.contributor.authorAbbas, Hassan
dc.contributor.authorBriggs, Andrew H
dc.contributor.authorCampbell, Karen
dc.contributor.authorChaudhuri, Rekha
dc.contributor.authorChoudhury, Gourab
dc.contributor.authorDawson, Dana
dc.contributor.authorDe Soyza, Anthony
dc.contributor.authorFielding, Shona
dc.contributor.authorGompertz, Simon
dc.contributor.authorHaughney, John
dc.contributor.authorLang, Chim C
dc.contributor.authorLee, Amanda
dc.contributor.authorMacLennan, Graeme
dc.contributor.authorMacNee, William
dc.contributor.authorMcCormack, Kirsty
dc.contributor.authorMcMeekin, Nicola
dc.contributor.authorMills, Nicholas L
dc.contributor.authorMorice, Alyn
dc.contributor.authorNorrie, John
dc.contributor.authorPetrie, Linda
dc.contributor.authorPrice, David
dc.contributor.authorShort, Philip
dc.contributor.authorVestbo, Jørgen
dc.contributor.authorWalker, Paul
dc.contributor.authorWedzicha, Jadwiga A
dc.contributor.authorWilson, Andrew
dc.contributor.authorLipworth, Brian J
dc.date.accessioned2022-04-18T13:20:01Z
dc.date.available2022-04-18T13:20:01Z
dc.date.issued2022-04-14
dc.identifier214985373
dc.identifier386c91c0-4344-48fe-953b-d3ee2d487dfb
dc.identifier35422024
dc.identifier85128291727
dc.identifier85128291727
dc.identifier000782603900007
dc.identifier.citationCotton , S , Devereux , G , Abbas , H , Briggs , A H , Campbell , K , Chaudhuri , R , Choudhury , G , Dawson , D , De Soyza , A , Fielding , S , Gompertz , S , Haughney , J , Lang , C C , Lee , A , MacLennan , G , MacNee , W , McCormack , K , McMeekin , N , Mills , N L , Morice , A , Norrie , J , Petrie , L , Price , D , Short , P , Vestbo , J , Walker , P , Wedzicha , J A , Wilson , A & Lipworth , B J 2022 , ' Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD) : a randomised controlled trial. (BICS) ' , Trials , vol. 23 , no. 1 , 307 . https://doi.org/10.1186/s13063-022-06226-8en
dc.identifier.issn1745-6215
dc.identifier.otherORCID: /0000-0002-1039-5646/work/111707638
dc.identifier.urihttps://hdl.handle.net/2164/18440
dc.descriptionAcknowledgments We are grateful for the secretarial and data co-ordination support from Janice Cruden. We would like to acknowledge the principal investigators and staff based in trial recruitment sites across the country, the Clinical Research Networks and staff in the Clinical Trials Pharmacy, and the support of the Trial Steering and Data Monitoring Committees. In particular, we have been grateful for the input to the Trial Steering Committee from two lay representatives, Mr Alister Laird and Mr Dave Bertin. Funding {4b} This project was funded by the National Institute for Health Research, Health Technology Assessment Programme (project number 15/130/20). The cardiac sub-study is funded by British Heart Foundation (BHF) Project Grant no. PG/17/64/33205. This report presents independent research commissioned by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, MRC, CCF, NETSCC, the Health Technology Assessment programme or the Department of Health.en
dc.format.extent16
dc.format.extent2225289
dc.language.isoeng
dc.relation.ispartofTrialsen
dc.subjectCOPDen
dc.subjectexacerbationen
dc.subjectrandomised controlled trialen
dc.subjectbisoprolen
dc.subjectbeta blockeren
dc.subjectR Medicineen
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject15/130/20en
dc.subjectBritish Heart Foundationen
dc.subjectPG/17/64/33205en
dc.subjectSupplementary Informationen
dc.subject.lccRen
dc.titleUse of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD) : a randomised controlled trial. (BICS)en
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.contributor.institutionUniversity of Aberdeen.Grampian Data Safe Haven (DaSH)en
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Sciences - Cardiovascular Groupen
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Medical Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Statisticsen
dc.contributor.institutionUniversity of Aberdeen.Rowett Instituteen
dc.description.statusPeer revieweden
dc.identifier.doi10.1186/s13063-022-06226-8


Files in this item

Thumbnail
Name:
Cotton_etal_T_Use_Of_The_VoR.pdf
Size:
2.122Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record